NF-κB-activated fibroblasts orchestrate inflammaging and emergence of pro-inflammatory granzyme K

Summary

This mechanistic study shows that age-dependent NF-κB activation in tissue fibroblasts remodels local immune architecture, driving emergence of pro-inflammatory/exhausted granzyme K–expressing cells—positioning fibroblasts as active drivers of inflammaging and candidate therapeutic targets to modulate age-associated inflammation.

Key Findings

• Age-dependent activation of NF-κB occurs in tissue fibroblasts and remodels immune architecture.
• This fibroblast NF-κB activation is associated with emergence of granzyme K (GZMK)-expressing exhausted/pro-inflammatory cells.
• Fibroblasts act as tissue drivers of inflammaging, representing potential therapeutic targets to modulate immune aging.

Clinical Implications

Suggests that targeting NF-κB signaling in tissue fibroblasts or modulating pathways leading to granzyme K–expressing exhausted cells could be therapeutic strategies to reduce inflammaging and its downstream age-related diseases; translational studies required.

Limitations

• Abstract fragment does not specify experimental systems, sample sizes, or causal intervention results in detail
• Translational and clinical relevance requires further in vivo validation and therapeutic studies

Future Directions

Validate causal role of fibroblast NF-κB using targeted genetic/pharmacologic inhibition in vivo, map downstream signaling to granzyme K induction, and explore translational interventions in age-related inflammatory diseases.